**Core Concept:** Hyperprolactinemia is an abnormally elevated level of prolactin in the blood, which can occur due to various factors including certain medications. Prolactin is a hormone secreted by the anterior pituitary gland and plays a role in lactation, menstrual cycle regulation, and male sexual function.

**Why the Correct Answer is Right:** Nafazol (also known as Cabergoline) is a dopamine D2 receptor agonist often used to treat hyperprolactinemia. By binding to the D2 receptors in the anterior pituitary gland, it suppresses the release of prolactin, leading to a decrease in serum prolactin levels.

**Why Each Wrong Option is Incorrect:**

A. **Option A:** Tranylcypromine is an antidepressant that can cause hyperprolactinemia due to its selective inhibition of the monoamine oxidase (MAO) enzyme. However, it does not directly act on the pituitary gland to suppress prolactin release.

B. **Option B:** Risperidone is an antipsychotic medication that can cause hyperprolactinemia due to its partial antagonism of D2 receptors in the hypothalamus, leading to increased prolactin secretion from the anterior pituitary gland.

C. **Option C:** Amlodipine is a calcium channel blocker used for hypertension management. It does not directly affect prolactin levels and is not associated with hyperprolactinemia.

D. **Option D:** Melatonin is a hormone involved in regulating sleep and circadian rhythm, not directly related to prolactin levels or hyperprolactinemia.

**Clinical Pearl / High-Yield Fact:** Prolactin levels can be monitored during the initiation or adjustment of medications known to cause hyperprolactinemia, such as tricyclic antidepressants, antipsychotics, and dopamine agonists like cabergoline. This helps in assessing medication adherence, side effect monitoring, and adjusting treatment plans accordingly.